Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Julphar
Baxter
Colorcon
Cantor Fitzgerald
Deloitte

Generated: September 24, 2019

DrugPatentWatch Database Preview

Patent: 9,668,915

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,668,915
Title:Drug eluting ocular implant
Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
Inventor(s): Haffner; David (Mission Viejo, CA), Curry; Ken (Oceanside, CA), Heitzmann; Harold (Irvine, CA), Applegate; David (Laguna Hills, CA)
Assignee: DOSE MEDICAL CORPORATION (San Clemente, CA)
Application Number:13/989,037
Patent Claims:see list of patent claims

Details for Patent 9,668,915

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26   Try a Free Trial DOSE MEDICAL CORPORATION (San Clemente, CA) 2031-11-22 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26   Try a Free Trial DOSE MEDICAL CORPORATION (San Clemente, CA) 2031-11-22 RX search
Genentech LUCENTIS ranibizumab INJECTABLE; INJECTION 125156 001 2006-06-30   Try a Free Trial DOSE MEDICAL CORPORATION (San Clemente, CA) 2031-11-22 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Daiichi Sankyo
Baxter
Chubb
Teva
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.